Clinical Trial Update: Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer

View source ↗

Summary

This clinical trial update reports long-term survival outcomes for patients with unresectable hepatocellular carcinoma treated with a lenvatinib-based therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Unresectable Hepatocellular Carcinoma | Status: ACTIVE_NOT_RECRUITING